SEO URLwww.firestrike.ai/deals/curevac-biontech-se-acquisition-2026-6
acquisitionAnnounced · Jan 9, 2026biotechnologySource · CredibleArticle · Factual
BioNTech SE acquires CureVac
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
$1.25B
Target
CureVac
Tuebingen, Baden-Wuerttemberg
Acquirer
BioNTech SE
Full Acquisition
Status
Announced
BioNTech SE agreed to acquire CureVac. Reported deal value: $1.25B. Status: Announced. Sector: biotechnology. Target headquarters context: Tuebingen, Baden-Wuerttemberg, Germany.
This page summarizes publicly available information about the transaction as of 2026-01-09. Figures and status may change as filings and press coverage update.
MarketMinute January 09, 20 26 at 10:57 AM EST In a move that signals the end of an era for independent mRNA pioneers, BioNTech SE has officially completed its acquisition of longtime rival CureVac N.V.
Deal timeline
Announced
Jan 9, 2026 · markets.financialcontent.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in biotechnology with a reported deal value of $1.25B. Figures and status may change as sources update.
Sources: markets.financialcontent.com · Primary article · FireStrike proprietary index